Research | Clinical Trials | Clinical Trial Details Page

The Effects of ?-9-THC and Naloxone in Humans

Conditions

Healthy

Trial Phase

Phase 1

Trial Purpose and Description

Trial Purpose

The purpose of this project is to examine the effects of mu-opiate antagonism on the rewarding and reinforcing effects of delta-9-tetrahydrocannabinol (THC), the main psychoactive ingredient of cannabis.


Participation Guidelines

Age:
18 Years - 55 Years
Gender:
Both

Eligibility Criteria


Inclusion Criteria:

- At least one exposure to Cannabis

Exclusion Criteria:

- Cannabis Naive
Sponsor:
Yale University
Dates:
July 2011
Last Updated:
March 11, 2013
Study HIC#:
1108008940

Clinicaltrials.gov ID: NCT01591629